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Abstract
 
Plasmacytoid predendritic cells or type 1 interferon (IFN)-producing cells (IPCs) have recently
been identified in mice. Although culture systems giving rise to different murine dendritic cell
subsets have been established, the developmental regulation of murine plasmacytoid IPCs and
the culture conditions leading to their generation remain unknown. Here we show that large
numbers of over 40% pure CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
Gr-1
 
 
 
 IPCs can be generated from mouse
bone marrow cultures with FLT3-ligand. By contrast GM-CSF or TNF-
 
 
 
, which promote the
generation of CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
 myeloid DCs, block completely the development of
IPCs. IPCs generated display similar features to human IPCs, such as the plasmacytoid mor-
phology, the ability to produce large amounts of IFN-
 
 
 
 in responses to herpes simplex virus,
and the capacity to respond to ligands for Toll-like receptor 9 (TLR-9; CpG ODN 1668), but
not to ligands for TLR-4 (lipopolysaccharide [LPS]). Unlike human IPCs which produce little
IL-12p70, mouse IPCs produce IL-12p70 in response to CpG ODN 1668 and herpes simplex
virus. This study demonstrates that the development of murine CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
Gr-1
 
 
 
IPCs and CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
 myeloid DCs is differentially regulated by FLT3-ligand and
granulocyte/macrophage colony-stimulating factor. Human IPCs and mouse IPCs display
different ability to produce IL-12p70. Large numbers of mouse IPCs can now be obtained
from total bone marrow culture.
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Introduction
 
Plasmacytoid predendritic cells (pre-DC2) or type 1 IFN-
producing cells (IPCs) represent a unique cell type of the
hematopoietic system (1–5). IPCs in both humans and
mice display a plasmacytoid morphology and have the ca-
pacity to produce large amounts of type 1 IFN in response
to viral and bacterial stimulation (1–5). In addition, IPCs
have the potential to differentiate into dendritic cells,
which are capable of inducing naive T cell proliferation
(6–9). Human IPCs display a unique phenotype: CD4
 
 
 
CD45RA
 
 
 
BDCA2
 
 
 
CD123
 
2
 
 
 
CD11c
 
 
 
Lin
 
 
 
 (6–9). Recently,
mouse IPCs have been identified by their capacity to pro-
duce large amounts of type 1 IFN in response to stimula-
tion by virus or bacteria (3–5). Unlike human IPCs, mouse
IPCs express CD11c, and markers for B cells (B220) and
granulocyte (GR-1), but do not express high CD123. In
addition, mouse IPCs express high levels of CD45RB and
Ly6c. The identification of mouse IPCs further supports the
concept that IPCs may represent a pivotal effector cell type
in antiviral immunity and opens the possibility to study
their function in vivo.
During the past years, the developmental pathways of
mouse DC subsets and the molecular regulation of their
generation has been extensively studied. Mouse myeloid
DCs were generated from mouse bone marrow (BM) or
from peripheral blood monocytes with GM-CSF, or
GM-CSF plus IL-4 (10). Mouse “lymphoid DCs” were
generated from thymic lymphoid precursors in the pres-
ence of a combination of IL-1
 
 
 
, TNF-
 
 
 
, IL-7, stem cell
factor (SCF), and IL-3 (11). However, the developmental
regulation of mouse IPCs and the culture conditions lead-
ing to the generation of large numbers of mouse IPCs are
currently unknown.
Previous studies demonstrated that injection of FLT3-
ligand and G-CSF could significantly increase the number of
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IPCs in the blood of human volunteers (12, 13). In addition,
FLT3-ligand but not G-CSF was shown to induce a propor-
tion of human CD34
 
 
 
CD45RA
 
 
 
 early hematopoietic stem
cells to differentiate into IPCs in culture (14). In this study,
we demonstrate that the development of murine CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
Gr-1
 
 
 
 IPCs is promoted by FLT3-ligand in
total BM cultures. GM-CSF or TNF-
 
 
 
 inhibited the devel-
opment of murine IPCs, but promoted the development of
CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
 myeloid DCs. Unlike human IPCs
that do not have the ability to produce IL-12p70, murine
IPCs readily produce IL-12 in response to viruses or bacteria.
It is now possible to generate large numbers of over 40% pure
IPCs in mouse total BM culture with FLT3-ligand.
 
Materials and Methods
 
Mice.
 
Female BALB/c mice (Taconic Farm) at 6–8 wk old
were used as a source of BM, for the generation of mouse DCs in
cultures.
 
Cell Isolation and Culture.
 
BM cells were isolated by flushing
femurs and tibiae with RPMI supplemented with 10% heat inacti-
vated FCS. The BM cells were then passed through a 70-
 
 
 
m cell
strainer, centrifuged, and resuspended in a tris-ammonium chloride
buffer (Sigma-Aldrich) at 37
 
 
 
C for 5 min to lyze red blood cells.
The cells were centrifuged and resuspended at 10
 
6
 
 cells/ml in cul-
ture medium consisting of RPMI 1640, 10% FCS, 1 mmol/liter so-
dium pyruvate, hepes, penicillin, streptomycin, and 2-mercaptoeth-
anol supplemented with different cytokines: murine FLT3-ligand
(100 ng/ml; DNAX Research Institute), GM-CSF (100 ng/ml;
Kenilworth), FLT3-ligand plus TNF-
 
 
 
 (10 ng/ml; R&D Systems),
FLT3-ligand plus GM-CSF, and GM-CSF plus TNF-
 
 
 
. Every 5 d
of culture, half of the medium was removed and fresh cytokine-
supplemented culture medium was added back into cultures.
 
Flow Cytometric Analysis and Cell Sorting.
 
Cells were harvested
at day 10 of culture and stained with anti-CD11c-PE mAb,
anti-CD11b-APC mAb and FITC-labeled anti-B220 mAb, anti-
CD45RB, anti-Ly6c, anti-GR1, anti-CD4, anti-CD8, anti-
CD80, anti CD86, anti-CD40, and anti-MHC class II mAbs (all
from BD PharMingen). For cell sorting the cells were stained with
anti-B220 FITC mAb, anti-CD11c-PE mAb, anti-CD11b-APC
mAb, and CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
 and CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
were sorted.
 
In Vitro Stimulation and Quantitation of Cytokine Production.
 
Sorted CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
 and CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
 cells
were cultured for 24 h at 10
 
5
 
 cells/200 
 
 
 
l in round-bottom 96-
well culture plates in the presence of: irradiated HSV at 30 PFU/
cell, Toll-like receptor (TLR)-4 ligand LPS from 
 
Salmonella mine-
ssota 
 
serotype RE595 (Sigma-Aldrich) at 10 
 
 
 
g/ml, and TLR-9
ligand CPG-ODN 1668 (TCCATGACGTTCCGATGCT; MWG
Biotech) at 1 
 
 
 
M. CPG was added twice at 0 and 12 h to the cul-
ture. For quantitation of cytokine production, cell-free superna-
tants were collected after 24 h and analyzed with the following
ELISA kits: mouse IFN-
 
 
 
 (PBL-Biomedical), mouse TNF-
 
 
 
(R&D Systems), and mouse IL-12p70 (R&D Systems).
 
Results
 
Murine CD11c
 
 
 
CD11b
 
 
 
 DC Subset Generated in FLT3-
Ligand-supplemented BM Cultures Displays a Phenotype of
Murine IPCs.
 
FLT3-ligand was shown to induce the gener-
ation of large numbers of CD11c
 
 
 
 DCs in mice (15). How-
ever, it was not determined whether IPCs were generated
in this system. We investigated whether FLT3-ligand
could induce the generation of mouse IPCs in cultures of
total BM cells. Murine BM cells were cultured in the pres-
ence of 100 ng/ml FLT3-ligand for 20 d. During the first
5 d of culture, a rapid loss of B cells (CD19
 
 
 
), T cells
(CD3
 
 
 
), NK cells (DX5
 
 
 
), and granulocytes (GR1
 
 
 
CD11c
 
 
 
)
was observed by flow cytometric analysis (Fig. 1 A). How-
ever, there was a dramatic increase in the percentage of
CD11c
 
 
 
 cells, from 1.2% before culture to 37% at day 5
of culture and to a maximal level of over 92% after day 10
of culture (Fig. 1 A). The total cellularity of the cultures
reached its maximum at day 10, equaling the BM cell in-
put number at day 0 (Fig. 1 B). Because mouse IPCs
were recently shown to express CD11c, B220, GR-1,
CD45RB, and Ly6c, but not CD11b (3, 4, 5), we investi-
gated whether the CD11c
 
 
 
 cells generated in culture
contained cells with IPC phenotype by three color flow
Figure 1. (A) Percentage of CD3 , CD19 , DX5 , GR1/CD11c ,
and CD11c  cells analyzed by flow cytometry. During the first 5 d of cul-
ture, a rapid loss of B cells (CD19 ), T cells (CD3 ), NK cells (DX5 ),
and granulocytes (GR1 CD11c ) was observed. However, there was a
dramatic increase in the percentage of CD11c  cells. (B) Total cell number
harvested from FLT3-ligand–supplemented BM cultures at day 0, 5, 10,
15, and 20. There was an initial cell loss at day 5 of cell culture. However,
cell number was recovered by day 10 and then decreased after. Repre-
sented is the mean   SD of three independent experiments. 
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cytometry. Fig. 2 A shows that two subsets of DCs,
CD11c
 
 
 
CD11b
 
 
 
 and CD11c
 
 
 
CD11b
 
 
 
 are generated in
FLT3-ligand supplemented BM cultures. The CD11c
 
 
 
CD11b
 
 
 
 subset, which represented 
 
 
 
1% of total BM
cells before culture, increased to 16% of total cultured cells
at day 5, peaked at day 10 with 45%, and then decreased
to 21% at day 15 of culture (Fig. 2 A). The CD11c
 
 
 
CD11b
 
 
 
 subset expressed high levels of B220, CD45RB,
Ly6c, and GR-1, low levels of MHC class II, and unde-
tectable levels of CD80 and CD86 (Fig. 2 B), the typical
phenotype of mouse plasmacytoid DC precursors (3–5).
The CD11c
 
 
 
CD11b
 
 
 
 subset which represented 
 
 
 
0.2%
of total BM cells before culture, increased to 13% of total
cultured cells at day 5, to 32% at day 10, and to 49% at day
15 of culture (Fig. 2 A). The CD11c
 
 
 
CD11b
 
 
 
 subset did
not express B220 and expressed lower levels of CD45RB,
Ly6c, and GR-1, but expressed significant levels of CD80,
CD86, and MHC class II, the typical phenotype of splenic
myeloid DC subsets (16–18). Both CD11c
 
 
 
 cell popula-
tions lacked lineage markers for B cells (CD19), T cells
(CD3), NK cells (DX-5), and erythroid cells (TER-119)
(data not shown). Therefore, FLT3-ligand induced the
generation of over 90% pure CD11c
 
 
 
 cells at day 10 of
murine BM cultures. While 
 
 
 
50% of the CD11c
 
 
 
 cells
displayed the phenotype of the splenic CD11b
 
 
 
 myeloid
DC subset, the other 50% of the CD11c
 
 
 
 cells displayed
the phenotype of IPCs.
CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
 DC subset displays a plasmacy-
toid morphology and produce a large amounts of IFN-
 
 
 
in response to Herpes simplex virus. We separated the
CD11c
 
 
 
 cells derived from day 10 BM culture with
FLT3-ligand into two subsets, CD11c
 
 
 
CD11b
 
 B220 
and CD11c CD11b B220 , by three-color immunofluo-
rescence cell sorting. Whereas the CD11c CD11b B220 
subset displayed plasmacytoid morphology, the CD11c 
CD11b B220  cells displayed a morphology, similar to
that of the splenic CD11c CD11b  myeloid DCs (data
not shown). The CD11c CD11b B220  subset produced
large amounts of IFN-  in response to HSV (2,884  
24; 2,664   22; 2,160   32 pg/ml/106 cells, from
three separate donors; Fig. 3). By contrast, the
CD11c CD11b B220  myeloid DC subset only pro-
duced low amounts of IFN-  in response to HSV (34  
0; 108   6; 25   10 pg/ml/106 cells; Fig. 3). In addition,
the CD11c CD11b B220  subset, but not the CD11c 
CD11b B220  myeloid DC subset produced a moderate
amounts of TNF-  in response to HSV (Fig. 3). These
data indicate that CD11c CD11b B220  cells generated
in culture are IPCs, a key cell type in antiviral innate im-
munity.
Unlike Human IPCs, Murine CD11c CD11b B220 
IPCs Produce IL-12 in Response to HSV and CpG. Previ-
ous studies demonstrated that human IPC had a poor abil-
ity to produce IL-12p70, compared with monocyte-
derived DCs in response to CD40-ligand or microbial
stimulation (19–21). Mouse CD11c CD11b B220  IPCs
generated in cultures produced a large amounts of IL-12p70
in response to CpG ODN 1668 (2,092   16; 1,282   10;
1,586   50 pg/ml/106 cells from three separate donors),
which was 4–5 times more than that produced by the
CD11c CD11b B220  myeloid DCs (168   8; 150  
0.4; 46   17 pg/ml/106 cells; Fig. 3). In addition, the
CD11c CD11b B220  IPCs, but not the CD11c 
CD11b B220  myeloid DCs produced a moderate amount
of IL-12p70 in response to HSV (Fig. 3). These data con-
firm the recent reports that freshly isolated mouse IPCs
produce both IFN-  and IL-12 in responses to viruses (4),
or bacteria (5).
Figure 2. Generation of CD11c 
CD11b B220  IPCs and the
CD11c CD11b B220  myeloid
DCs from FLT3-ligand-supple-
mented BM cell cultures. Three-
color fluorescence flow cytome-
try analysis shows that CD11c 
CD11b  cells represent 1% of to-
tal BM cells before culture, and
16% at day 5, 45% at day 10, and
21% at day 15 of culture with
FTL3-ligand (A). The CD11c 
CD11b  cells display a typical phe-
notype of mouse IPCs, being
B2202 CD45RB2 Ly6c2 Gr-12 
CD80 CD86 MHC class IIlow (B).
The CD11c CD11b  cells repre-
sent 0.2% of total BM cells before
culture, and 13% at day 5, 32% at
day 10, and 49% at day 15 of culture
with FTL3-ligand (A). The
CD11c CD11b  cells display a
phenotype similar to that of the
splenic myeloid DCs, being B220 
CD45RB Ly6c Gr-1 -  CD80 
CD86 MHC class IIhigh (B). The
data shown are representative of
six experiments.956 Murine Plasmacytoid DC Development
CD11c CD11b B220  IPCs Respond Poorly to LPS.
Recent studies have shown that human IPCs preferentially
respond to the TLR-9 ligands (bacterial CpG ODN), but
do not respond to the TLR-4 ligands (LPS), by producing
IFN-  and TNF- , and differentiate into DCs (19–21).
While CD11c CD11b B220  IPCs produced large
amounts of IFN- , IL-12p70, and TNF-  (6,014   270;
10,570   522; 5,754   211 pg/ml/106 cells from three
separate donors) in response to CpG ODN 1668 (Fig. 3),
and differentiate into mature DCs (data not shown), they
produced neither IFN- , nor IL-12p70, and a very low
amount of TNF-  (234   10; 78   0.4; 82   14 pg/ml/
106 cells) in response to LPS (Fig. 3). CD11c CD11b 
B220  IPCs did not differentiated into mature DCs and
died after 24 h of culture with LPS. By contrast, the
CD11c CD11b B220  myeloid DCs produced 6 to 13
times more TNF-  (1,366   103.6; 1,008   39.6; 1,298  
69 pg/ml/106 cells) than CD11c CD11b B220  IPCs
(Fig. 3), and displayed an increased ability to induce anti-
gen-specific naive T cell proliferation following activation
by LPS (data not shown).
GM-CSF and TNF-  Inhibit the Generation of CD11c 
CD11b B220  IPCs in FLT3-ligand-supplemented BM
Cultures. GM-CSF represents a key DC growth and dif-
ferentiation factor both in vivo and in vitro (22). GM-CSF
or GM-CSF plus TNF- , cytokines used classically to gen-
Figure 3. Cytokine production
by the CD11c CD11b B220 
IPCs and the CD11c CD11b 
B220  myeloid DCs in cultures
with medium, LPS, CpG ODN
1668, and HSV. Each solid circle
represents a separate donor. The
sensitivity of ELISA for detecting
each cytokine: IFN-  (  12.5
pg/ml), TNF-  (  25 pg/ml),
and IL-12 (15 pg/ml).
Figure 4. GM-CSF and TNF- 
promotes the generation of
CD11c CD11b B220  myeloid
DCs and inhibits the FLT3-
ligand-mediated generation of
CD11c CD11b B220  IPCs.
Freshly isolated BM cells were
cultured for 10 d with FLT3-
ligand, GM-CSF, or FLT3-ligand
plus GM-CSF, FLT3-ligand plus
TNF- , or GM-CSF plus TNF- .
Three-color fluorescence flow cy-
tometry analyses shows that both
CD11c CD11b B220  IPCs
(42%) and CD11c CD11b B220 
myeloid DCs (30%) were gener-
ated at day 10 of BM culture with
FLT3-ligand as shown in Fig. 2.
Addition of TNF-  lead to a de-
crease of CD11c CD11b B220 
IPCs from 42 to 6%, and an in-
crease of CD11c CD11b B220  myeloid DCs from 30% to 60%. Addition of GM-CSF lead to a complete blockage of the generation of
CD11c CD11b B220  IPCs, and an increase of CD11c CD11b B220  myeloid DCs from 30 to 80%. In total BM cultures with either GM-CSF, or
GM-CSF plus TNF- , only CD11c CD11b B220  myeloid DCs, but not CD11c CD11b B220  IPCs were generated. The data shown are represen-
tative of three experiments.957 Gilliet et al. Brief Definitive Report
erate human and murine DCs in vitro, induced a single
population of CD11c CD11b B220  myeloid DCs but
no CD11c CD11b B220  IPCs in total BM culture (Fig.
4). The CD11c CD11b B220  DCs generated with GM-
CSF or GM-CSF plus TNF-  displayed a similar pheno-
type to CD11c CD11b B220  DCs generated with
FLT3-ligand (Fig. 2). Addition of GM-CSF or TNF-  to
the FLT3-ligand cultures inhibited the generation of
CD11c CD11b B220  IPCs (Fig. 4). These results dem-
onstrate that the development of IPCs and CD11c 
CD11b B220  DCs are regulated by different hematopoi-
etic cytokines.
Discussion
In this study, we report that large numbers of over 40%
pure murine IPCs can be generated in FLT3-ligand–sup-
plemented BM cultures within 10 d. The study suggests
that FLT3-ligand and GM-CSF/TNF-  have opposing ef-
fects on the development of CD11c CD11b B220  IPCs
and CD11c CD11b B220  myeloid DCs, and that FLT3-
ligand represents a key cytokine for IPC development in
both humans and mice.
One striking difference between human and mouse IPCs
is that mouse IPCs readily produce both IL-12 p70 and
IFN- , whereas human IPCs only make IFN-  in re-
sponse to viral and bacterial stimulation. IFN-  has the
ability to induce IFN-  production from T cells in hu-
mans, but not in mice, because a mutation in STAT2 gene
in mice, which results in a loss of type 1 IFN-induced
STAT4 activation in mouse T cells (23). It is therefore
highly likely that human but not mice IPCs have lost the
ability to make IL-12p70 in response to virus and bacteria,
due to the functional redundancy of human IFN-  and IL-
12p70 in their ability to induce IFN-  production in hu-
man T cells.
It has been proposed that human and mouse IPCs (pre-
DC2) play a central role in antiviral innate immunity. In-
deed, depletion of IPCs was found to be associated with
progression of HIV-infected subjects to AIDS (24–26).
Furthermore, it has been suggested that mature DCs de-
rived from IPCs (pre-DC2) may induce adaptive immune
responses with regulatory functions (27, 28). Recent stud-
ies suggest that inappropriate activation of IPCs may be
associated with the pathophysiology of systemic lupus
erythematosus (29, 30). The generation of large numbers
of CD11c CD11b B220  IPCs by FLT3-ligand-supple-
mented BM cultures will permit further studies of their de-
velopment and their in vivo function in the innate and
adaptive immunity.
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